Flexing Your HIV Prevention Muscles and Mastering PrEP Implementation
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten JM, et al. N Engl J Med. 2012;367(5):399-410.
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.
Truvada: emtricitabine/tenofovir disoproxil.
European Medicines Agency (EMA). 2018.
Emtricitabine/tenofovir alafenamide.
HIV.gov. Drug database.
Emtricitabine/tenofovir disoproxil fumarate.
HIV.gov. Drug database.
Cabotegravir.
HIV.gov. Drug database.
Being PrEPared—preexposure prophylaxis and HIV disparities.
Goldstein RH, et al. N Engl J Med. 2018;379(14):1293-1295.
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant RM, et al. N Engl J Med. 2010;363(27):2587-2599.
Lifetime risk of a diagnosis of HIV infection in the United States.
Hess KL, et al. Ann Epidemiol. 2017;27(4):238-243.
Cabotegravir for HIV prevention in cisgender men and transgender women.
Landovitz RJ, et al. N Engl J Med. 2021;385(7):595-608.
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Mayer KH, et al. Lancet. 2020;396(10246):239-254.
Clinical Commissioning Policy. Reimbursement for the use of generic drugs for pre exposure prophylaxis (PrEP) for the prevention of HIV.
National Health Service. 2020.
How to incorporate HIV PrEP into your practice.
Stewart J, Stekler JD. J Fam Pract. 2019;68(5):254-261.
Clinical Practice Guidelines
Recommendations for integrated sexual health services for trans, including non-binary, people.
British Association for Sexual Health and HIV (BASHH); 2019.
UK national guideline for consultations requiring sexual history taking.
BASHH; 2019.
Guidance during disruption of STD clinical services.
Centers for Disease Control and Prevention; March 2022.
Sexually transmitted infections treatment guidelines. 2021.
Centers for Disease Control and Prevention. Last reviewed July 2021.
2018 quick reference guide: recommended laboratory HIV testing algorithm for serum or plasma specimens.
CDC Stacks. Centers for Disease Control and Prevention; last updated January 2018.
Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016.
CDC Stacks. Centers for Disease Control and Prevention; last updated May 2018.
HIV pre-exposure prophylaxis in the EU/EEA and the UK: implementation, standards and monitoring: technical guidance.
European Centre for Disease Prevention and Control (ECDC). 2021.
The Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health.
Makadon H, et al, American College of Physicians (ACP), eds. 2nd ed. Boston, MA: Fenway Health; 2015.
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society—USA Panel.
Saag MS, et al. JAMA. 2020;324(16):1651-1669.
Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update). A clinical practice guideline.
US Public Health Service. Centers for Disease Control and Prevention; 2021.
Professional Organizations & Resources
American Academy of HIV Medicine.
Basic statistics.
Centers for Disease Control and Prevention; updated April 2022.
British Association for Sexual Health and HIV.
British HIV Association.
National AIDS Trust.
National Clinician Consultation Center.
University of California, San Francisco; 2020.
HIV drug interactions.
University of Liverpool (website); updated April 2022.
PrEP’ing Your HIV Prevention Muscles: PrEP WHAT and WHY
A CME Circuit Training™ Activity
| Faculty: | Isolde Butler, MD, MPH; Raphael Landovitz, MD, MSc; Daniel Richardson FRCP, FAChSHM |
| Release: | 05/06/2022 |
| Expiration: | 05/06/2023 |
Go for the Gold in Sexual Health Assessment: Determining PrEP Eligibility
A CME Circuit Training™ Activity
| Faculty: | Isolde Butler, MD, MPH; Raphael Landovitz, MD, MSc; Daniel Richardson FRCP, FAChSHM |
| Release: | 05/06/2022 |
| Expiration: | 05/06/2023 |
Put Me in, Coach! I’m Ready for PrEP: Implementation 101
A CME Circuit Training™ Activity
| Faculty: | Isolde Butler, MD, MPH; Raphael Landovitz, MD, MSc; Daniel Richardson FRCP, FAChSHM |
| Release: | 05/06/2022 |
| Expiration: | 05/06/2023 |
